Advanced Search
HUANG Yuan, XU You-fen. Serum Copper, Ferritin Levels in Patients with Lung Cancer[J]. Cancer Research on Prevention and Treatment, 1999, 26(4): 275-277.
Citation: HUANG Yuan, XU You-fen. Serum Copper, Ferritin Levels in Patients with Lung Cancer[J]. Cancer Research on Prevention and Treatment, 1999, 26(4): 275-277.

Serum Copper, Ferritin Levels in Patients with Lung Cancer

More Information
  • Objective: To evaluate the relation between serum copper and serum ferritin in cancer patients. Methods: The levels of serum copper, ferritin in 27 patients with lung cancer and 45 normal subjects were determined. Results: The results showed that the levels of serum copper of lung cancer patients were higher than the healthy controls (P <0.01). The levels of serum ferritin of lung cancer patients were higher than the healthy controls too (P<0.01). Using correlativity analysis, the highly positive correlation was found between serum copper and serum ferritin (P<0.005). Conclusion: The results suggest that higher serum ferritin levels in the lung cancer patients may be due to higher levels of ceruloplasmin.
  • [1]
    Hazard JT, etal. Ferritinaemia in cancer. Nature, 1977, 265: 755;
    [2]
    Roeser HP, etal. The role of ceruloplasmin in iron metabolism. J Clin Invest, 1970, 49: 2408;
    [3]
    Alexander J, etal. Bi liary excretion of copper and zinc in the rat as influenced by diethylmaleate, selenite and di ethyldithiocarbamate. Biochem Pharmac, 1980, 29: 2129;
    [4]
    Niederau C, etal. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med, 1985, 313: 1256;
    [5]
    黄源.机体铁超载与肿瘤. 癌症, 1994, 13: 368;
    [6]
    孔祥瑞.必需微量元素的营养、生理及临床意义. 第1版.合肥: 安徽科学技术出版社, 1982: 20-154;
    [7]
    Nelson RL, Dietary iron and colorectal caneer risk. Fre Rad Biol Med, 1992, 12: 161.
  • Cited by

    Periodical cited type(18)

    1. 付艳杰,郭文静,段鹏月,刘星辰. CAR-T细胞免疫疗法对复发/难治性弥漫大B细胞淋巴瘤患者LDH、ALC、CD4+/CD8+、Ki67表达的影响. 实用癌症杂志. 2024(01): 78-82 .
    2. 张盛琪,蒋佩珍,高琰,刘青果,张朝畅,唐旭东. 较高危骨髓增生异常综合征伴原始细胞增多患者的中医证候特征及早期死亡危险因素研究. 北京中医药大学学报. 2024(03): 429-439 .
    3. 孙邡,桑艳. 腹膜后肾肿瘤切除术治疗儿童双侧肾母细胞瘤疗效及对围手术期指标和术后并发症的影响. 临床和实验医学杂志. 2024(08): 853-857 .
    4. 杨婷婷,黄一丹,杨蓉蓉,杨莹,张敬. 2型糖尿病合并慢性牙周炎患者血清LRG1、LDH与牙周指标和牙周病变程度的关系. 实用医学杂志. 2024(16): 2250-2255 .
    5. 王英英,关珊珊,全建峰,任革,贾永军,韩冬. 小细胞肺癌患者血清LDH和proGRP与血浆D-D水平评估化疗疗效及预后的效能. 中国临床研究. 2023(03): 398-403 .
    6. 罗旭,王千千,党会芬,王玉凤,田迎霞. 血清乳酸脱氢酶与转移性胃癌姑息性化疗患者生存期的关系. 兰州大学学报(医学版). 2023(03): 39-45 .
    7. 闫隔,赵娜,张营. 胃肠胰神经内分泌肿瘤中GSK-3β、LDHA表达及其与临床病理特征的关系. 河南医学研究. 2023(09): 1616-1619 .
    8. 王思宇,李佳蔚,李程豪,李玲,郭晴阳,邱璐,周世琴,刘永琦. 乳酸脱氢酶A在消化系统肿瘤中的作用及相关药物研究进展. 中国临床药理学与治疗学. 2023(04): 445-454 .
    9. 宫业宏,白宏宇,陈天龙,方文星. 术前乳酸脱氢酶/白蛋白比值对肝细胞癌患者预后推断的价值分析. 医学理论与实践. 2023(13): 2175-2177 .
    10. 廖奕娇,程馨缘,易铁钢. 蒿甲醚通过调节氧化应激改善阿霉素诱导小鼠心肌损伤的作用研究. 中药新药与临床药理. 2022(03): 319-324 .
    11. 张硕,钟政昌,宋鑫龙,徐本韩,张玉红. LDH抑制剂筛选方法的优化及西藏药材中的应用. 食品工业. 2022(03): 155-159 .
    12. 周永婕,王正峰,严俊,王海平,徐雯,周文策. 术前乳酸脱氢酶/白蛋白比值联合AFP评估肝细胞癌患者预后的价值. 肿瘤防治研究. 2022(04): 347-351 . 本站查看
    13. 庄思远,周旭,刘箬瑶,刘春明,李赛男,张语迟. 茯神中乳酸脱氢酶抑制剂的提取筛选与质谱分析. 食品工业. 2022(04): 16-22 .
    14. 崔杨,曲璇. 乳酸在肿瘤中的作用及乳酸脱氢酶作为治疗靶点的研究进展. 肿瘤预防与治疗. 2022(06): 572-578 .
    15. 丁晨. C反应蛋白、乳酸脱氢酶和β_2-微球蛋白检测对急性白血病患者治疗预后评估中的价值. 系统医学. 2022(20): 17-20+25 .
    16. 胡忠利,杨艳丽,潘少君. 急性白血病中超敏C反应蛋白及乳酸脱氢酶的表达特点及临床意义. 现代医药卫生. 2021(14): 2337-2339 .
    17. 倪玉芳,张树军,方天星,万军,陈洁,曾凡才. 黄胸鼠Ldha基因的克隆、原核表达及酶学性质研究. 四川动物. 2021(06): 601-610 .
    18. 杨夏影,马银娟,师丽丽,吉小凡,潘耀柱. 多发性骨髓瘤有氧糖酵解的研究进展. 医学研究杂志. 2021(11): 12-15 .

    Other cited types(17)

Catalog

    Article views (1145) PDF downloads (524) Cited by(35)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return